Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Based Compensation

Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

Stock-based compensation

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of revenues

 

$

51

 

 

$

80

 

 

$

145

 

 

$

444

 

Sales and marketing

 

 

20

 

 

 

24

 

 

 

51

 

 

 

156

 

General and administrative

 

 

154

 

 

 

699

 

 

 

1,280

 

 

 

2,818

 

Research and development

 

 

17

 

 

 

35

 

 

 

56

 

 

 

244

 

Total stock-based compensation

 

$

242

 

 

$

838

 

 

$

1,532

 

 

$

3,662

 

Schedule of Restricted Stock Unit Activity

A summary of our restricted stock unit activity for the nine months ended September 30, 2024 is set forth below:

 

 

 

Shares

 

 

Weighted
Average Grant
Date Fair Value

 

Outstanding as of December 31, 2023

 

 

96,808

 

 

$

25.21

 

Granted

 

 

84,081

 

 

 

5.63

 

Released

 

 

(127,834

)

 

 

11.93

 

Forfeited

 

 

(2,530

)

 

 

17.47

 

Outstanding as of September 30, 2024

 

 

50,525

 

 

$

26.61

 

Schedule of Stock Option Activity summary of our stock option activity under the 2018 Equity Incentive Plan (the “2018 Plan) and related information is as follows:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (years)

 

Aggregate
Intrinsic
Value

 

Outstanding as of December 31, 2023

 

 

2,500

 

 

$

56.89

 

 

4.2

 

$

-

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

Forfeited

 

 

-

 

 

 

-

 

 

 

 

 

 

Outstanding as of September 30, 2024

 

 

2,500

 

 

$

56.89

 

 

3.69

 

$

-

 

Exercisable as of September 30, 2024

 

 

2,500

 

 

$

56.89

 

 

3.69

 

$

-